Literature DB >> 11376906

A new model of visceral pain and referred hyperalgesia in the mouse.

J M A Laird1, L Martinez-Caro, E Garcia-Nicas, F Cervero.   

Abstract

The generation of transgenic mice that lack or overexpress genes relevant to pain is becoming increasing common. However, only one visceral pain model, the writhing test, is widely used in mice. Here we describe a novel model, chemical stimulation of the colon, which we have developed in mice. Mice of either sex were injected i.v. with 30 mg/kg Evan's Blue for subsequent determination of plasma extravasation. For behavioural testing, they were placed on a raised grid and 50 microl of saline, mustard oil (0.25-2.5%) or capsaicin (0.03-0.3%) was administered by inserting a fine cannula into the colon via the anus. Visceral pain-related behaviours (licking abdomen, stretching, contractions of abdomen etc) were counted for 20 min. Before intracolonic administration, and 20 min after, the frequency of withdrawal responses to the application of von Frey probes to the abdomen was tested. The colon was removed post-mortem and the Evan's Blue content measured. Mustard oil and capsaicin administration evoked dose-dependent visceral pain behaviours, referred hyperalgesia (significant increase in responses to von Frey hairs) and colon plasma extravasation. The peak behavioural responses were evoked by 0.1% capsaicin and by 1% mustard oil respectively. The nociceptive behavioural responses were dose-dependently reversed by morphine (ED50 = 1.9 +/- 1 mg/kg s.c.). We conclude that this model represents a useful tool both for phenotyping mutant mice and for classical pharmacology since information on visceral pain, referred hyperalgesia and colon inflammation can all obtained from the same animal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376906     DOI: 10.1016/S0304-3959(01)00275-5

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  108 in total

1.  Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: influence of surgery and postoperative single housing on visceromotor responses.

Authors:  Muriel Larauche; Guillaume Gourcerol; Mulugeta Million; David W Adelson; Yvette Taché
Journal:  Stress       Date:  2010-07       Impact factor: 3.493

2.  Transient receptor potential ion channels V4 and A1 contribute to pancreatitis pain in mice.

Authors:  Eugene Ceppa; Fiore Cattaruzza; Victoria Lyo; Silvia Amadesi; Juan-Carlos Pelayo; Daniel P Poole; Natalya Vaksman; Wolfgang Liedtke; David M Cohen; Eileen F Grady; Nigel W Bunnett; Kimberly S Kirkwood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-10       Impact factor: 4.052

3.  Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations.

Authors:  Louis P Vera-Portocarrero; Ying Lu; Karin N Westlund
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

Review 4.  Recent advances in understanding molecular mechanisms of primary afferent activation.

Authors:  J N Wood
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

5.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.

Authors:  Karin N Westlund; Liping Zhang; Fei Ma; Helieh S Oz
Journal:  Transl Res       Date:  2011-11-08       Impact factor: 7.012

6.  Uropathogenic Escherichia coli induces chronic pelvic pain.

Authors:  Charles N Rudick; Ruth E Berry; James R Johnson; Brian Johnston; David J Klumpp; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 7.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

8.  The water avoidance stress induces bladder pain due to a prolonged alpha1A adrenoceptor stimulation.

Authors:  Rita Matos; Paula Serrão; Larissa Rodriguez; Lori Ann Birder; Francisco Cruz; Ana Charrua
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-31       Impact factor: 3.000

9.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

10.  Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.

Authors:  Marta Sobczak; Gerta Cami-Kobeci; Maciej Sałaga; Stephen M Husbands; Jakub Fichna
Journal:  Eur J Pharmacol       Date:  2014-05-06       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.